Thus, blood testing for ALT is used globally as a minimally invasive and inexpensive tool for detecting chronic liver diseases, such as non-alcoholic fatty liver disease (NAFLD) [1]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.